{
      "title": "SUT BEZI SARATONI KASALLIGINI KIMYOTERAPIYA BILAN DAVOLASHNING YUTUQ VA KAMCHILIKLARI",
      "keywords": "sut bezi saratoni, kimyoterapiya, doksorubitsin, paklitaksel, neoadjuvant terapiya, toksiklik, umumiy omon qolish.",
      "datestamp": "2026-06-19 04:54:39",
      "eprintid": 95691,
      "date": "2026-03-29",
      "status_changed": "2026-06-19 04:54:39",
      "volume": 3,
      "publication": "INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY",
      "metadata_visibility": "show",
      "eprint_status": "archive",
      "ispublished": "pub",
      "rev_number": 3,
      "number": 2,
      "full_text_status": "public",
      "documents": [
          {
            "rev_number": 2,
            "docid": 17317,
            "uri": "https://arxiv.universalpublishings.com/id/document/17317",
            "pos": 1,
            "security": "public",
            "placement": 1,
            "eprintid": 95691,
            "content": "published",
            "format": "application/pdf",
            "main": "53-55.pdf",
            "language": "en",
            "files": [
                {
                  "mtime": "2026-06-19 04:54:39",
                  "filesize": 233075,
                  "hash_type": "MD5",
                  "objectid": 17317,
                  "mime_type": "application/pdf",
                  "filename": "53-55.pdf",
                  "hash": "6212d81de535f4965a683aef358b3fa5",
                  "fileid": 140344,
                  "uri": "https://arxiv.universalpublishings.com/id/file/140344",
                  "datasetid": "document"
                }
            ]
          }
      ],
      "type": "article",
      "abstract": "Sut bezi saratoni (SBS) ayollar orasida eng ko\u2018p uchraydigan onkologik kasallik bo\u2018lib, global o\u2018lim sabablaridan biri hisoblanadi. Kimyoterapiya kasallikning erta va rivojlangan bosqichlarida muhim davolash usuli sifatida qo\u2018llaniladi. Ayniqsa, antrasiklinlar, taksanlar va platina asosidagi preparatlar adjuvant, neoadjuvant hamda metastatik bosqichlarda samarali hisoblanadi. Ushbu maqolada kimyoterapiyaning klinik samaradorligi, omon qolish ko\u2018rsatkichlariga ta\u2019siri hamda nojo\u2018ya ta\u2019sirlari tahlil qilinadi.",
      "official_url": "https://universalconference.us/index.php/icast/article/view/6903",
      "pagerange": "53-55",
      "dir": "disk0/00/09/56/91",
      "lastmod": "2026-06-19 04:54:39",
      "creators": [
        {
          "name": {
            "honourific": null,
            "family": "Jumayev M. Yu",
            "given": "Jumayev M. Yu",
            "lineage": null
          }
        },
        {
          "name": {
            "family": "Xayitova G. A",
            "honourific": null,
            "lineage": null,
            "given": "Xayitova G. A"
          }
        },
        {
          "name": {
            "honourific": null,
            "family": "Xalilova  X. A",
            "given": "Xalilova  X. A",
            "lineage": null
          }
        }
      ],
      "uri": "https://arxiv.universalpublishings.com/id/eprint/95691"
    }